ScoreWhy is Mankind Pharma Ltd ?
1
Flat results in Sep 25
- INTEREST(9M) At Rs 530.87 cr has Grown at 122.24%
- PAT(Latest six months) At Rs 949.83 cr has Grown at -20.05%
- ROCE(HY) Lowest at 12.33%
2
With ROCE of 11.7, it has a Expensive valuation with a 4.7 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -15.75%, its profits have fallen by -17.2%
3
Below par performance in long term as well as near term
- Along with generating -15.75% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Mankind Pharma for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Mankind Pharma
-15.68%
-0.53
29.45%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.85%
EBIT Growth (5y)
14.48%
EBIT to Interest (avg)
40.81
Debt to EBITDA (avg)
1.27
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.81
Tax Ratio
18.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.76%
ROCE (avg)
21.63%
ROE (avg)
16.64%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
52
Industry P/E
34
Price to Book Value
5.95
EV to EBIT
39.95
EV to EBITDA
29.45
EV to Capital Employed
4.68
EV to Sales
7.10
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
11.72%
ROE (Latest)
11.44%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
OPERATING CF(Y)
Highest at Rs 2,322.16 Cr
NET SALES(9M)
At Rs 10,346.88 cr has Grown at 23.89%
PBDIT(Q)
Highest at Rs 921.33 cr.
-9What is not working for the Company
INTEREST(9M)
At Rs 530.87 cr has Grown at 122.24%
PAT(Latest six months)
At Rs 949.83 cr has Grown at -20.05%
ROCE(HY)
Lowest at 12.33%
DEBTORS TURNOVER RATIO(HY)
Lowest at 7.13 times
Loading Valuation Snapshot...
Here's what is working for Mankind Pharma
Operating Cash Flow - Annually
Highest at Rs 2,322.16 Cr
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 3,697.16 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 921.33 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Here's what is not working for Mankind Pharma
Interest - Nine Monthly
At Rs 530.87 cr has Grown at 122.24%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit After Tax (PAT) - Latest six months
At Rs 949.83 cr has Grown at -20.05%
Year on Year (YoY)MOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Lowest at 7.13 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
